Leuthold Group’s iShares Biotechnology ETF IBB Stock Holding History

Leuthold Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.4M	Sell	12,614 -648	-5%	-$111K	0.24%	131
2026 Q1	$2.24M	Sell	13,262 -4,926	-27%	-$842K	0.24%	129
2025 Q4	$3.07M	Buy	18,188 +5,285	+41%	+$858K	0.33%	116
2025 Q3	$1.86M	Buy	+12,903	New	+$1.76M	0.2%	128
2021 Q2	–	Sell	-2,604	Closed	-$392K	–	185
2021 Q1	$392K	Sell	2,604 -1,286	-33%	-$204K	0.05%	141
2020 Q4	$589K	Buy	3,890 +206	+6%	+$29.4K	0.08%	131
2020 Q3	$499K	Buy	3,684 +1,346	+58%	+$183K	0.07%	123
2020 Q2	$320K	Buy	+2,338	New	+$298K	0.05%	126

Other funds holding IBB

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Leuthold Group's IBB Position: Q2 2026 in Review

Leuthold Group reduced its iShares Biotechnology ETF (IBB) stake by 4.9% in Q2 2026, selling an estimated $111K and leaving 12,614 shares worth $2.4M. The position accounts for 0.24% of the portfolio, ranked #131.

Leuthold Group first reported a position in IBB in Q2 2020 and has held it in 8 quarters since. The position peaked at $3.07M in Q4 2025. 822 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Leuthold Group held 12,614 shares of iShares Biotechnology ETF worth $2.4M as of Q2 2026.
Leuthold Group sold 648 iShares Biotechnology ETF shares in Q2 2026, an estimated $111K.
iShares Biotechnology ETF made up 0.24% of Leuthold Group's portfolio in Q2 2026, its #131 holding.
Leuthold Group first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 8 quarters since.
Leuthold Group's iShares Biotechnology ETF position peaked at $3.07M in Q4 2025.
822 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Leuthold Group's 13F filing for Q2 2026, filed 4 Aug 2026.